Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Theranostics|April 1, 2020
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinomaThomas Kryza, Tashbib Khan, Simon Puttick, et al.
Toxicologic Pathology|November 15, 2013
Mechanistic investigations of test article-induced pancreatic toxicity at the endocrine-exocrine interface in the ratKarrie A Brenneman, Shashi K Ramaiah, Cynthia M Rohde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast CancersMadeline Gough, Kayden K X Kwah, Tashbib Khan, et al.
Environmental and Molecular Mutagenesis|January 17, 2012
International round-robin study on the Ames fluctuation testG Reifferscheid, H M Maes, B Allner, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014Michael A Brodney, David D Auperin, Stacey L Becker, et al.
The Journal of Infectious Diseases|April 5, 2020
A High-Fat Diet Increases Influenza A Virus-Associated Cardiovascular DamageJurre Y Siegers, Boris Novakovic, Katina D Hulme, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's diseaseMichael A Brodney, David D Auperin, Stacey L Becker, et al.
Cell|April 3, 2021
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionRichard J Mills, Sean J Humphrey, Patrick R J Fortuna, et al.
Research Square|April 10, 2023
Biochemical activity induced by a germline variation in <i>KLK3</i> (PSA) associates with cellular function and clinical outcome in prostate cancerSrilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, et al.
Pageof 10